Corneal Disease
37
5
5
17
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.4%
2 terminated out of 37 trials
89.5%
+3.0% vs benchmark
5%
2 trials in Phase 3/4
18%
3 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (37)
Evaluation of the Clinical Efficacy and Mechanisms of Cord Plasma Eye Drops in the Treatment of Neuropathic Corneal Pain
Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness
Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease
QST for Corneal Nerve Function
Prospective Study to Validate the Imaging Biomarker for NCP (R33)
Artificial Intelligence for Screening of Multiple Corneal Diseases
First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness
Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.
Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa
Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
Photorefractive Intrastromal Crosslinking (PiXL) for the Treatment of Progressive Keratoconus
Agreement and Precision Study of the Nidek Mirante
Dresden Corneal Disease and Treatment Study
NGF Treatment for Patients With Neuropathic Corneal Pain
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory
Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
Rapid Computerized Visual Acuity Test
Correlation Between Q-value Changes and Progression of Pediatric Keratoconus.